GlassScriptPhysician profile
David Michael Bittenbinder
NPI 1306283361
$2,156.42
in general payments reported to CMS, 2019-2025
23 companies · $888 in 2025
The $888 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.54 · 2020: $23.96 · 2021: $79.86 · 2022: $275 · 2023: $379 · 2024: $449 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $478.52 | 2023-2025 | Gattex, Eohilia |
| Medtronic, INC. | $409.90 | 2022-2025 | Signia, Ligasure, Sonicision |
| Smith+Nephew, INC. | $233.73 | 2023-2025 | Collagenase Santyl, Grafix Pl, Renasys Touch |
| Dilon Technologies, INC. | $166.39 | 2025 | Hemoblast Bellows |
| Acera Surgical, INC. | $123.83 | 2021-2025 | Restrata Wound Matrix |
| Solventum Corporation | $118.68 | 2024-2025 | Prevena, Activ.A.C., V.A.C. Veraflo |
| Davol INC. | $110.89 | 2022-2025 | Arista |
| Csl Behring | $84.21 | 2021-2023 | Kcentra |
| Innovation Technologies INC | $60.24 | 2023-2025 | Irrisept |
| W. L. Gore & Associates, INC. | $57.17 | 2024-2025 | Gore Synecor Biomaterial |
| Kerecis Limited | $41.73 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbvie INC. | $33.67 | 2021-2022 | |
| Teleflex LLC | $27.79 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $25.40 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.60 | 2023 | Exparel |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $23.96 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $23.61 | 2023 | Andexxa |
| Integra Lifesciences Corporation | $22.63 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.98 | 2022 | |
| Boston Scientific Corporation | $17.94 | 2019 | |
| Convatec INC. | $17.68 | 2023 | |
| Kci USA, INC. | $17.06 | 2023 | Prevena, V.A.C. Veraflo |
| Z-Medica, LLC | $15.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bittenbinder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.